Continuing Education

Pharmacology for Advanced Practice Nurses Online Courses

Sessions available on:

Why take these courses?

  • Excellent speakers
  • Latest evidence-based practice is used
  • Continuing education credit available
  • Oklahoma Board of Nursing approved pharmacology contact hours - Level C (Not approved for CNS's seeking initial prescriptive authority)
  • Courses can be taken individually or in combinations, take all seven for cost savings

Process

The process is easy...just register for your selected sessions. We will send you links to selected sessions. Watch the presentations from your computer, take a brief quiz, and you will receive a certificate by e-mail within a few weeks.

Cost

The cost is $25 per course and $100 for all the courses (a $75 cost savings). Additionally, 3 of the subjects are bundled together for $50 and 4 of the subjects are bundled together for $75.

Additional Information

The University of Oklahoma College of Nursing is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation. #UOC-0613 expiration June 30, 2013.

This activity is co-sponsored by the University of Oklahoma College of Nursing and the Oklahoma Association of Clinical Nurse Specialists.

Accommodations on the basis of disability are available by calling (405) 271-2062 48 hours in advance of workshop.

The University of Oklahoma is an equal opportunity institution.

I through VI have been approved by the Oklahoma Board of Nursing for 1.0 Pharmacology contact hour - Level Cfor Advanced Practice Nurses; session VII has been approved for 2 pharmacology contact hours - Level C. It is the responsibility of the nurse to determine whether the course content is relevant to their scope of practice when submitting hours earned in this course for a portion of their prescriptive authority continuing education. Those completing each 50 minute session will be awarded .83 contact hours of continuing nursing education credit.

Those successfully completing all seven modules will be awarded 8.0 pharmacology contact hours - Level C approved by the Oklahoma Board of Nursing and 6.7 continuing nursing education contact hours. The University of Oklahoma College of Nursing is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation. #UOC-0613 expiration June 30, 2013

For description of sessions, see below. To register for all sessions, click here. To register for individual sessions, see each topic below. Also, note at the bottom of the page, special bundling prices available.

Description of Sessions

SESSION I: Management of C. Difficile
50 minutes
Cost: $25.00
Register for this session

Presenter: Debbie Poland PharmD BCPS, Emergency Department Clinical Pharmacist at Norman Regional Hospital

Objectives:

  1. Discuss the pathophysiology and clinical presentation of Clostridium difficile-associated disease (CDAD)
  2. Discuss risk factors associated with CDAD
  3. Discuss epidemiology and prevention of CDAD
  4. Discuss disease management guidelines and current treatment strategies of CDAD
  5. Discuss key points in the pharmacologic management of CDAD, including:
    1. medications / medication classes
    2. how each medication / medication class is utilized
    3. management of adverse reactions and alternative therapeutic approaches
    4. drug interactions and side effects
    5. monitoring parameters and follow up
  6. Demonstrate the clinical application of the pharmacologic content through case study application.

SESSION II: Community Acquired Pneumonia
50 minutes
Cost: $25.00
Register for this session

Presenter: Yvette Morrison PharmD BCPS -Completed a pharmacy specialty residency in infectious diseases; oversee the antibiotic monitoring program at Norman Regional Health System.

Objectives:

  1. Review the epidemiology of community-acquired pneumonia (CAP) in adults
  2. Review the symptoms and diagnosis of CAP
  3. Identify the most common etiologies associated with CAP
  4. Provide empiric antibiotic treatment for CAP

SESSION III: MRSA: Who let the bugs out? Resistant Bacteria
 50 minutes
Cost: $25.00
Register for this session

Presenter: Marilee Obritsch PharmD BCPS, ICU Pharmacist and Clinical Educator at Hillcrest Medical Center.

Objectives:

  1. Describe the current trends of methicillin-resistant Staphylococcus aureus
  2. (MRSA) infections in health care institutions and the community.
  3. Explain the difference between health care associated and community acquired MRSA.
  4. Discuss appropriate pharmacotherapy management of health care associated
  5. and community acquired MRSA.

SESSION IV: Management of Pulmonary Hypertension
50 minutes
Cost: $25.00
Register for this session

Presenter: Stacey Rose, RN, MS, CNS- Outpatient Pulmonary Clinic

Objectives

  1. Review the pathophysiology of pulmonary hypertension
  2. Discuss disease management guidelines and current treatment strategies.
  3. Discuss the key points in the pharmacologic management of pulmonary
    Hypertension including medications/ medication classes used for management of pulmonary hypertension and how each medication class is utilized in the management of the disease.
  4. Present management of adverse reactions Identify possible drug interactions and side effects.
  5. Discuss the monitoring parameters and follow up care for the individual with pulmonary arterial hypertension.
  6. Demonstrate the clinical application of the pharmacologic content through case study application.

SESSION V: COPD - What Works and What Does
50 minutes
Cost: $25.00
Register for this session

Presenter: Sally Tibbals RN, MS, CNS-BC - Pulmonary CNS and CNS faculty at OU College of Nursing

Objectives:

  1. Assess the severity of disease in COPD
  2. Review the latest evidence-base in the care of the COPD patient.
  3. Compare and contrast decisions in selecting interventions for the COPD patient
  4. Discuss current approaches to selecting therapy for the COPD patient based upon the recent update of the GOLD guidelines

SESSION VI: Renal Precautions 50 minutes
Cost: $25.00
Register for this session

Presenter: Ruth Ann Fritz RN, CNN, CNS, Nephrology Clinical Nurse Specialist

Objectives:

  1. Participant will be able to calculate the GFR for a patient and state interventions (and usual medications) for each stage of CKD.
  2. Participate will be able to identify proper renal dosages for classes of medications.
  3. Participant will verbalize precautions to preserve renal function.

SESSION VII: Management of Acute Versus Chronic Heart Failure
100 minutes
Cost: $25.00
Register for this session

Presenters: Debbie Crawford CNS and Debbie Pound CNS - Heart Failure Clinical Nurse Specialist.

Objectives

  1. Identify clinical signs and symptoms for acutely decompensated heart failure.
  2. Identify one key intervention in the treatment of acutely decompensated heart failure
  3. Identify discharge criteria when heart failure compensated
  4. Identify the primary classes of medications used to treat and manage chronic heart failure.
  5. Verbalize the pathophysiology of heart failure and the purpose for each class of heart failure medication.
  6. Identify medications within a class recommended as "best practice" in AHA heart failure guidelines.
  7. Summarize the diagnostic tests (radiological and laboratory) typically used in the diagnosis and treatment of chronic heart failure.

SESSION I-III: C. Difficile, Community-Acquired Pneumonia and MRSA
Cost: $50.00
Register for sessions I-III

SESSION IV-VII: Pulmonary Hypertension, COPD, Acute/Chronic Heart Failure, Renal Precautions
Cost: $75.00
Register for sessions IV-VII

SESSIONS I-VII:
Cost--$100.00
Register for all sessions

 
The University of Oklahoma Copyright © 2011 The Board of Regents of the University of Oklahoma, All Rights Reserved.
NPP and HIPAA Complaint Information | Equal Opportunity | Copyright | Disclaimer |